Acme United (ACU) Q3 2026 earnings review
Acme United sales accelerate, but high overhead holds back profit
Acme United, the maker of First Aid Only kits and Westcott scissors, grew sales while one-offs lifted profit. Sales from businesses owned a year ago rose 10%, and chief executive Walter C. Johnsen noted strong back-to-school demand. Reported profit jumped 80% on a $4 million tariff refund, but by our math underlying operating profit rose 9% after a $1.8 million plant-closure charge and higher overhead.
| Sales from businesses owned a year ago | +10% total revenue $58.0M, +18% from a year ago |
|---|---|
| Gross margin, excluding one-offs | 41.5% 39.1% a year ago (reported: 45.3%) |
| Operating profit, excluding one-offs | $3.3M +8.5% from a year ago (reported: $4.5M) |
| My Medic fourth-quarter profit outlook | Unchanged most of its full-year profit still expected in Q4 |
โ๏ธ Verdict: โช Neutral
The story is unchanged because higher selling and administrative expenses cancelled out the underlying gross margin gain. The good news is that first-aid demand accelerated across North America and retailers are committing to carry My Medic trauma kits next year. One caution: bank debt minus cash rose to $30 million despite the tariff refund, and My Medic still had minimal earnings impact through nine months.
The question now is whether My Medic's high overhead is a seasonal quirk or a permanent cost of selling online. If holiday volume covers its ad spend, fourth-quarter profit jumps; if not, group margins stay lower until retail stores carry the kits in 2027. Fourth-quarter selling expenses and My Medic earnings will decide it.
๐ Bull Case
Sales from Existing Lines Picked Up Across Regions
Acme United makes first-aid kits, medical supplies and Westcott scissors and cutting tools. Chief executive Walter C. Johnsen said, "We had record sales in the quarter, with growth in all our business units and internationally." Sales from businesses it owned a year ago rose 10%, picking up from 6% in the first quarter and 8% in the second.
- U.S. sales: up 20%, helped by the January purchase of My Medic
- Canada sales: up 9% in U.S. dollars and 12% in local currency on first-aid demand
- Europe sales: up 5% in U.S. dollars and 7% in local currency on online orders
Johnsen added that "Back-to-school sales were strong." That rebound matters because retailers cancelled school promotions a year ago when tariffs jumped, leaving an easy comparison for the U.S. business. Even so, Canada rebounded from 3% local-currency growth last quarter, showing that demand for first-aid kits is holding up across regions.
What to watch: the revenue breakdown by product category in the quarterly filing. It will show whether total cutting and sharpening sales matched the rebound in school promotions.
Tariff Refunds and My Medic Lifted Gross Margin
The company has been working through high-tariff inventory imported last year while adding robotics in its plants. This quarter it collected $6.0 million in tariff refunds under the International Emergency Economic Powers Act (IEEPA). It booked $4.0 million of that refund as a reduction in the cost of making its products, lifting gross margin by 6.9 percentage points, and kept $2.0 million on the balance sheet.
Acme United also took a $1.8 million charge in cost of goods sold to close a sharpening plant, which cut gross margin by 3.1 percentage points. Excluding both one-offs, gross margin was 41.5% by our math, up 2.4 percentage points from 39.1% a year ago. The company said the gain was "primarily driven by the inclusion of the new My Medic direct to consumer business", even as Johnsen noted that "Transportation and many raw materials are increasing in cost."
What to watch: U.S. gross margin excluding My Medic on the conference call. A positive reading would confirm that older tariff costs have cleared out of inventory before freight inflation bites.
Retailers Commit to Carry My Medic Next Year
Acme United bought My Medic, which sells trauma and emergency kits online to consumers, for $18.6 million in January. The plan is to put those kits into retail stores and industrial distributors where the group already sells First Aid Only products. Johnsen said the company is "beginning to receive retail and distribution commitments for its product lines next year."
Winning store shelves is important because online sales require heavy advertising in every quarter, while retail orders bring steady volume at lower marketing cost. Those commitments will not help revenue until 2027, so the business still relies on online shoppers for the rest of this year.
What to watch: named retail or industrial distribution wins on the fourth-quarter call. Signed rollouts for 2027 would show the acquisition can grow without matching every dollar of sales with online ads.
๐ป Bear Case
Overhead Costs Ate Up the Underlying Margin Gain
Headline net income jumped 80% to $3.4 million, helped by the tariff refund and $0.4 million of tax benefits from stock option exercises. Underneath the one-offs, selling, general and administrative expenses (advertising, shipping and overhead) rose to 37.6% of sales from 33.0% a year ago. The company still gives no revenue or earnings outlook, and customer concentration and leadership succession remain unaddressed.
- Overhead and marketing excluding the $1.0 million refund bonus: 35.9% of sales, up 2.9 percentage points by our math
- Operating profit excluding the refund, bonus and plant charge: $3.3 million, up 8.5% on 18% sales growth by our math
- Operating margin excluding one-offs: 5.6%, down from 6.1% a year ago by our math
That cost jump means My Medic's higher gross margin did not reach the bottom line. Even without the bonus tied to the tariff refund, overhead ran well above the ~33% full-year rate management targeted earlier this year, so underlying operating margin shrank.
What to watch: selling and overhead expenses as a share of sales in the fourth quarter. A ratio above 33% during the holiday peak would show that online marketing costs are permanently higher.
My Medic Still Needs a Fourth-Quarter Profit Jump
When Acme United bought My Medic, it said the business had about $19 million in yearly sales. Because the gap between total sales growth (18%) and underlying sales growth (10%) was 8 percentage points, My Medic added about $4.0 million of sales in the third quarter by our math, after $7.7 million in the first half.
The company said My Medic had minimal impact on earnings in both the third quarter and the first nine months. Reaching $19 million for the year now requires about $7.3 million of sales in the fourth quarter by our math, or nearly double the third-quarter pace, when consumer spending is under pressure.
What to watch: My Medic's fourth-quarter revenue and profit contribution in the annual filing. Falling short of $7 million in fourth-quarter sales would leave the $18.6 million acquisition barely profitable for its first year.
Higher Debt and Interest Costs Weigh on Cash
Johnsen said, "Our balance sheet is strong, and we continue to look for acquisitions that fit our strategic criteria." However, bank debt minus cash rose 29% from a year ago to $29.7 million, and rose by $2.4 million from the second quarter even though the company collected $6.0 million in cash tariff refunds.
Total balance-sheet debt reached $37.7 million, pushing net interest expense up 41% to $0.6 million in the quarter. Free cash flow over the past twelve months was $13.8 million, but excluding the $6.0 million tariff refund it was $7.8 million by our math, down from $11.1 million in the prior-year period.
What to watch: bank debt minus cash at year-end after the holiday selling season. Another increase would mean working capital and acquisition holdbacks are absorbing cash faster than operations generate it.
Closing the Massachusetts Plant Contradicts the Onshoring Story
For the past two years, Acme United has pitched U.S. manufacturing as its shield against import tariffs. This quarter Johnsen announced plans to "close our DMT plant in Massachusetts and shift production and fulfillment to other locations and offshore", moving production of DMT diamond sharpeners "to more cost-effective facilities in Asia".
The company accrued $1.8 million of closure costs in the third quarter and expects more than $1.0 million in yearly savings in 2027. Moving production to Asia lowers factory costs, but it increases exposure to future tariff hikes just after the company needed a $6.0 million refund to recover past tariff payments.
What to watch: whether production moves to China or to lower-tariff Asian countries on the call. Sourcing more goods from China would heighten the risk of another margin squeeze if trade tensions return.
๐ฒ Other KPIs
Inventories rose 14.7% from a year ago and $4.9 million from the second quarter. The safety and cutting-tool supplier ordered an extra $10 million of stock earlier this year to guard against shipping disruptions, and added My Medic stock, tying up cash ahead of the fourth quarter.
Money owed by customers for goods already shipped rose 20.5% from a year ago, slightly faster than the 18.2% increase in ุซุงูุซ-quarter sales. The rise reflects strong back-to-school shipments to U.S. retailers that will be collected in cash during the fourth quarter.
Diluted shares rose 3.1% from a year ago, up from a 0.9% increase in the second quarter, as employees exercised stock options. Those exercises cut third-quarter income tax expense by about $0.4 million, lifting reported net income, while spreading future profits across more shares.
๐ฎ Guidance
Unchanged. Management still expects the online trauma-kit business to earn most of its annual profit in the fourth quarter after breaking even through nine months. By our math, the $19 million annual sales frame leaves about $7.3 million for the fourth quarter, up from roughly $4.0 million in the third.
New. Closing the Massachusetts sharpening plant later this year and shifting work to Asia is set to save more than $1.0 million a year starting in 2027, following the $1.8 million closure charge booked in the third quarter.
โ Key Questions
How much did total cutting and sharpening sales grow?
Back-to-school sales were strong against last year's cancelled promotions, but the release did not give product-category numbers. The filing's breakdown will show whether non-Westcott lines shrank.
Why did overhead jump to 35.9% of sales excluding bonuses?
Even after stripping out the $1.0 million bonus tied to the tariff refund, selling and administrative costs rose 2.9 percentage points as a share of revenue and erased the gross margin gain.
Which Asian country will take on DMT sharpening production?
Moving DMT manufacturing offshore saves $1.0 million a year in 2027, but putting more production into China would raise tariff risk right after the IEEPA refund.
Are Med-Nap hospital certification and SmartCompliance scanners on track?
Management previously committed to finish hospital qualification at its Med-Nap wipes plant and ship next-generation first-aid scanners to distributors by the fourth quarter, and the release gave no update.